| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 5 | 40 | -0,11 % | ||
| VESTAS WIND SYSTEMS | 3 | 9 | +1,40 % | ||
| AP MOELLER-MAERSK | - | 23 | +0,50 % | ||
| ORSTED | - | 17 | -0,18 % | ||
| DANSKE BANK | - | 10 | +0,53 % | ||
| BAVARIAN NORDIC | - | 7 | +0,24 % | ||
| DSV | - | 4 | +0,33 % | ||
| ROCKWOOL | - | 4 | 0,00 % | ||
| CARLSBERG | - | 3 | +0,17 % | ||
| JYSKE BANK | - | 3 | -0,34 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:30 | Was bei Vestas Wind Systems gerade passiert: Droht jetzt der nächste große Absturz? - Positionieren Sie sich vor Börseneröffnung! | Hebelschein-Spekulant | |||
| 09:50 | Samstag-Meldung zu NOVO NORDISK A/S: Jetzt wird's heiß! | 32 | Maximilian Berger | ||
| 07:00 | Mesoblast Aktie: Vom Biotech - Hoffnungsträger zum kommerziellen Player - was Anleger jetzt von Eli Lilly, Novo Nordisk & Co. lernen können | Small- & Micro Cap Investment | |||
| Fr | Canada approves second generic version of Ozempic | 18 | Reuters | ||
| Fr | Health Canada approves 2nd generic version of Ozempic - and it's Canadian | 21 | BNN Bloomberg | ||
| Fr | Zealand Pharma proposes Camilla Sylvest for board election | 3 | Investing.com | ||
| Fr | Coloplast A/S: Coloplast Receives Innovative Technology Contract from Vizient for Biatain Silicone Fit | 102 | GlobeNewswire (Europe) | The contract is awarded for products that bring improvement to the healthcare industry. Coloplast, a global medical device company and market leader in intimate healthcare, has received an Innovative... ► Artikel lesen | |
| Fr | Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 | 5 | GlobeNewswire (USA) | ||
| Fr | The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting | 4 | GlobeNewswire (USA) | ||
| Fr | GoodRx: Ozempic-Tablette für Selbstzahler ab 149 US-Dollar erhältlich | 51 | Investing.com Deutsch | ||
| Fr | Weight Watchers adds Ozempic pill to diabetes treatment program | 27 | Investing.com | ||
| Fr | WW International Inc.: Weight Watchers Expands Med+ With Access to New Ozempic pill (semaglutide) | 17 | GlobeNewswire (USA) | ||
| Fr | Novo Nordisk's Rybelsus officially retired in US as 'Ozempic pill' takes branding center stage | 26 | FiercePharma | ||
| Fr | FLSmidth A/S: FLSmidth announces that Chief People Officer, Cori Petersen, will leave the company | 252 | GlobeNewswire (Europe) | PRESS RELEASEFLSmidth & Co. A/S1 May 2026Copenhagen, Denmark
FLSmidth & Co. A/S today announces that Cori Petersen, Chief People Officer & Global Business Services EVP, will be stepping down... ► Artikel lesen | |
| Fr | ISS World Services A/S: Update on ownership of ISS Türkiye | 213 | GlobeNewswire (Europe) | ISS, a leading global workplace experience and facility services company, today announces that it has reached an agreement with private equity firm Actera to acquire the firm's shares in ISS Türkiye.... ► Artikel lesen | |
| Fr | CIP acquires Ørsted's onshore business in Europe | 16 | Power Technology | ||
| Fr | CIP completes Orsted onshore acquisition | 4 | reNews | ||
| Fr | FLSmidth A/S: FLSmidth investigates potential non-compliance with sanctions regulations and takes steps to enhance compliance measures | 317 | GlobeNewswire (Europe) | PRESS RELEASEFLSmidth & Co. A/S1 May 2026Copenhagen, Denmark
FLSmidth has, as part of ongoing internal investigation, identified information indicating that certain pre-contract tender materials... ► Artikel lesen | |
| Fr | Danske Bank A/S, transactions by persons discharging managerial responsibilities | 4 | GlobeNewswire (USA) | ||
| Do | Hypera plans to launch its own 'Ozempic' 90 days after approval | 67 | Valor International |